• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清中期因子作为慢性心力衰竭患者心脏事件的预测因子。

Serum midkine as a predictor of cardiac events in patients with chronic heart failure.

机构信息

Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.

出版信息

J Card Fail. 2010 Apr;16(4):308-13. doi: 10.1016/j.cardfail.2009.12.014. Epub 2010 Feb 26.

DOI:10.1016/j.cardfail.2009.12.014
PMID:20350697
Abstract

BACKGROUND

Midkine, a heparin-binding growth factor, has various functions such as migration of inflammatory cell and anti-apoptotic effect. Invasion of inflammatory cell and cardiomyocyte apoptosis are involved in development and progression of heart failure (HF). However, the relationship between midkine and HF has not been previously examined. Therefore, we examined clinical significance of serum midkine levels to determine the prognosis of HF patients.

METHODS AND RESULTS

Serum levels of midkine were measured at admission in 216 consecutive patients hospitalized for HF and 60 control subjects. Patients were prospectively followed during a mean follow-up period of 653 +/- 375 days with the end points of cardiac death and progressive HF requiring rehospitalization. Serum concentrations of midkine were significantly higher in patients with HF than in controls. Patients with cardiac events had significantly higher concentrations of midkine than those without cardiac events. Kaplan-Meier analysis revealed that cardiac event rates increased markedly as midkine levels rose. Furthermore in the multivariate analysis, after adjustment for age, gender ,and complications, midkine was the independent predictor of cardiac events.

CONCLUSION

Serum midkine levels are increased in HF patients, and midkine is a novel marker for risk stratifying HF patients.

摘要

背景

中期因子(midkine)是一种肝素结合生长因子,具有迁移炎性细胞和抗细胞凋亡等多种功能。炎性细胞浸润和心肌细胞凋亡参与心力衰竭(HF)的发生和发展。然而,midkine 与 HF 之间的关系尚未被研究。因此,我们检测了血清 midkine 水平的临床意义,以确定 HF 患者的预后。

方法和结果

在 216 例连续住院 HF 患者和 60 例对照者入院时测定血清 midkine 水平。平均随访 653±375 天,终点为心脏死亡和需要再住院的进行性 HF。HF 患者的血清 midkine 浓度明显高于对照组。有心脏事件的患者 midkine 浓度明显高于无心脏事件的患者。Kaplan-Meier 分析显示,随着 midkine 水平的升高,心脏事件发生率显著增加。此外,在多变量分析中,调整年龄、性别和并发症后,midkine 是心脏事件的独立预测因子。

结论

HF 患者的血清 midkine 水平升高,midkine 是 HF 患者危险分层的新标志物。

相似文献

1
Serum midkine as a predictor of cardiac events in patients with chronic heart failure.血清中期因子作为慢性心力衰竭患者心脏事件的预测因子。
J Card Fail. 2010 Apr;16(4):308-13. doi: 10.1016/j.cardfail.2009.12.014. Epub 2010 Feb 26.
2
Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure.胱抑素C是一种评估肾功能的新指标,是心力衰竭患者心脏事件的独立预测因子。
J Card Fail. 2005 Oct;11(8):595-601. doi: 10.1016/j.cardfail.2005.06.001.
3
Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.3型五聚体蛋白,一种血管炎症的新标志物,可预测心力衰竭患者的不良临床结局。
Am Heart J. 2008 Jan;155(1):75-81. doi: 10.1016/j.ahj.2007.08.013. Epub 2007 Sep 27.
4
Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.在检测慢性心力衰竭患者正在发生的心肌损伤方面,心脏型脂肪酸结合蛋白比肌钙蛋白T更敏感。
J Card Fail. 2007 Mar;13(2):120-7. doi: 10.1016/j.cardfail.2006.10.014.
5
B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.B型利钠肽可预测急性心力衰竭且收缩功能保留患者的中期风险。
J Card Fail. 2005 Sep;11(7):498-503. doi: 10.1016/j.cardfail.2005.05.002.
6
High-density lipoprotein cholesterol levels and prognosis in advanced heart failure.高密度脂蛋白胆固醇水平与晚期心力衰竭的预后。
J Heart Lung Transplant. 2009 Sep;28(9):876-80. doi: 10.1016/j.healun.2009.04.026.
7
Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.N末端B型利钠肽原(NT-proBNP)在预测心力衰竭患者低功能状态、射血分数降低及心血管事件方面的临界值。
Cardiol J. 2009;16(1):43-9.
8
Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure.心肌肌钙蛋白I与晚期心力衰竭时的血流动力学受损、进行性左心室功能障碍及死亡率增加相关。
Circulation. 2003 Aug 19;108(7):833-8. doi: 10.1161/01.CIR.0000084543.79097.34. Epub 2003 Aug 11.
9
Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure.在扩张型心肌病和心力衰竭失代偿患者出院时,联合检测血清 tenascin-C 水平和血 B 型利钠肽对预后的预测价值。
J Card Fail. 2009 Dec;15(10):898-905. doi: 10.1016/j.cardfail.2009.06.443. Epub 2009 Aug 26.
10
Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.充血性心力衰竭合并孤立性左心室舒张功能障碍患者的患病率、临床特征、生活质量及预后
J Am Soc Echocardiogr. 2004 Mar;17(3):253-61. doi: 10.1016/j.echo.2003.11.002.

引用本文的文献

1
Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases.新型心脏生物标志物及多标志物方法在心脏病早期检测、预后评估及风险分层中的应用
World J Cardiol. 2025 Jul 26;17(7):106561. doi: 10.4330/wjc.v17.i7.106561.
2
Midkine Serum Levels in Inflammatory and Non-Inflammatory Dilated Cardiomyopathy.炎症性和非炎症性扩张型心肌病患者血清中期因子水平
Biomedicines. 2025 Feb 18;13(2):504. doi: 10.3390/biomedicines13020504.
3
Exploration of neuron heterogeneity in human heart failure with dilated cardiomyopathy through single-cell RNA sequencing analysis.
通过单细胞 RNA 测序分析探索人类扩张型心肌病心力衰竭中的神经元异质性。
BMC Cardiovasc Disord. 2024 Feb 3;24(1):86. doi: 10.1186/s12872-024-03739-9.
4
Novel Biomarkers for Atherosclerotic Disease: Advances in Cardiovascular Risk Assessment.动脉粥样硬化疾病的新型生物标志物:心血管风险评估的进展
Life (Basel). 2023 Jul 27;13(8):1639. doi: 10.3390/life13081639.
5
The secretome as a biomarker and functional agent in heart failure.分泌组作为心力衰竭中的生物标志物和功能因子
J Cardiovasc Aging. 2023 Jul;3(3). doi: 10.20517/jca.2023.15. Epub 2023 Jun 9.
6
Midkine-A novel player in cardiovascular diseases.中期因子——心血管疾病中的新角色。
Front Cardiovasc Med. 2022 Sep 20;9:1003104. doi: 10.3389/fcvm.2022.1003104. eCollection 2022.
7
Defining the Roles of Cardiokines in Human Aging and Age-Associated Diseases.确定心脏因子在人类衰老及与年龄相关疾病中的作用。
Front Aging. 2022 Apr 28;3:884321. doi: 10.3389/fragi.2022.884321. eCollection 2022.
8
Novel Biomarkers of Atherosclerotic Vascular Disease-Latest Insights in the Research Field.动脉粥样硬化性血管疾病的新型生物标志物——研究领域的最新见解。
Int J Mol Sci. 2022 Apr 30;23(9):4998. doi: 10.3390/ijms23094998.
9
Midkine release during hemodialysis is predictive of hypervolemia and associates with excess (cardiovascular) mortality in patients with end-stage renal disease: a prospective study.血液透析过程中中期因子的释放可预测血容量过多,并与终末期肾病患者的超额(心血管)死亡率相关:一项前瞻性研究。
Int Urol Nephrol. 2022 Sep;54(9):2407-2420. doi: 10.1007/s11255-022-03141-4. Epub 2022 Feb 24.
10
Serum circulating proteins from pediatric patients with dilated cardiomyopathy cause pathologic remodeling and cardiomyocyte stiffness.来自扩张型心肌病儿科患者的血清循环蛋白导致病理性重构和心肌细胞僵硬。
JCI Insight. 2021 Oct 8;6(19):e148637. doi: 10.1172/jci.insight.148637.